A 38-year-old man with schizophrenia has been on risperidone 6 mg/day for 2 years. He presents with complaints of breast enlargement and galactorrhea. Which is the most common endocrine side effect associated with antipsychotic use?

Explanation

## Most Common Endocrine Side Effect of Antipsychotics **Key Point:** Hyperprolactinemia is the most frequent endocrine adverse effect of antipsychotics, particularly with typical and risperidone (atypical with high D2 affinity). ### Mechanism Antipsychotics block dopamine D2 receptors in the tuberoinfundibular pathway. Dopamine normally exerts tonic inhibition on prolactin release from lactotroph cells. Dopamine antagonism → loss of inhibition → elevated prolactin. ### Clinical Manifestations | Feature | Details | |---------|----------| | **Incidence** | 40–90% of patients on typical antipsychotics; 20–50% on risperidone; <10% on aripiprazole or quetiapine | | **Symptoms** | Galactorrhea, gynecomastia, amenorrhea, sexual dysfunction, infertility | | **Timeline** | Can occur within weeks of initiation | | **Gender** | Affects both males and females | ### Comparative Antipsychotic Prolactin Risk | Drug Class | Prolactin Risk | Notes | |-----------|----------------|-------| | **Typical (haloperidol, chlorpromazine)** | Very high | Strongest D2 blockade in tuberoinfundibular tract | | **Risperidone** | High | High D2 affinity; crosses blood–brain barrier readily | | **Paliperidone** | High | Active metabolite of risperidone | | **Amisulpride** | High | Selective D2 antagonist | | **Olanzapine** | Moderate | Lower prolactin elevation than risperidone | | **Quetiapine** | Low | Weak D2 affinity; rapid dissociation | | **Aripiprazole** | Very low | Partial D2 agonist; may lower prolactin | | **Clozapine** | Low | Minimal effect on prolactin | **High-Yield:** Hyperprolactinemia is the **most common endocrine complication** and often the reason for medication non-compliance in young patients. ### Management Strategies 1. Switch to low-prolactin agent (aripiprazole, quetiapine, clozapine) 2. Dose reduction if clinically feasible 3. Add dopamine agonist (bromocriptine) — rarely used due to psychosis risk 4. Monitor prolactin levels and clinical symptoms **Clinical Pearl:** Aripiprazole, a partial D2 agonist, may paradoxically *lower* prolactin levels and is an excellent choice for patients with prolactin-related side effects. ### Why Other Options Are Less Common - **Hypothyroidism:** Occurs but is less frequent than hyperprolactinemia; more often drug-induced (lithium) or autoimmune. - **Hyperglycemia:** Important metabolic side effect (especially olanzapine, clozapine) but less common than hyperprolactinemia. - **Hypogonadism:** Secondary consequence of chronic hyperprolactinemia; not a primary direct effect. [cite:Stahl's Essential Psychopharmacology 6e Ch 5]